TAG:
quality control
PennState Geisinger Building “ Distributed Lab ” Around POCT
CEO SUMMARY: Here’s an integrated healthcare system that’s pushing its clinical laboratory across traditional barriers between physician’s office and clinical lab. At PennState Geisinger Healthcare, a fast-growing health system located in rural Pennsylvania, point-of-care testing is…
Diagnostics Companies React To Changing Lab Marketplace
CEO SUMMARY: During the last five years, extensive consolidation among in vitro diagnostics (IVD) manufacturers has created a new class of industry giants. Their increased dominance of the IVD marketplace promises significant change to how laboratories acquire and use reagents, test kits,…
Washington’s PacLab Network Succeeds With Standardization
PART TWO OF TWO PARTS CEO SUMMARY: In part one of this two-part series, we looked at how changes to healthcare in the state of Washington brought about the creation of PacLab Network Laboratories. In this concluding installment, we explore how PacLab is standardizing lab…
Kaiser Plans Widespread Use For Pap Technology
WITHIN THE HMO INDUSTRY, Kaiser Permanente is highly respected for its thorough research into the clinical efficacy and economic cost of new healthcare technologies. That is the reason why Kaiser’s decision to adopt NeoPath, Inc.’s automated cytology technology…
AutoPap System Cleared For Primary Screening
CEO SUMMARY: It is time for pathologists and cytologists to buckle their safety belts. The marketplace for automated cytology is entering a new cycle of rapid change. NeoPath’s AutoPap System is now poised to demonstrate that it is economical and clinically viable. Expect continual impr…
Automated Pap Screening Gains Recommendation
CEO SUMMARY: Automated cytology technology received a big boost when the FDA’s advisory panel voted to recommend that the FDA approve, with conditions, NeoPath’s AutoPap® System as a primary Pap Smear Screener. The company still awaits final FDA approval on this matter….
Pap Smear Technologies Battle For Market Share
CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three compan…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.